Vol. 6, Issue 12 (2017)

Author(s):
Vytryhovskiy Andriy Іgorovych

Abstract:
The aim: was to develop and implement the concept of prevention and treatment of fatal complications in patients with post-infarction cardiosclerosis based on the evaluation of the heart rate slowdown. Materials and methods: The article presents an analysis of 100 Holter monitorings of patients with post-infarction cardiosclerosis on the background therapy with beta-blockers (bisoprolol) and phosphocreatine (Neoton). Results: Treatment with bisoprolol leads to a decrease in the rate of acceleration of the cardiac rhythm, the anti-fibrilative effect of the combination of bisoprolol-phosphocreatine occurs at the expense of more physical protection, namely, an increase in the activity of the parasympathetic system. Conclusion: Use of phosphocreatine in patients with post-infarction cardiosclerosis and coherent phenomenon of heart rhythm turbulence can optimize the prevention of sudden cardiac death among these individuals.